Chenguang Medical Overview
- Year Founded
-
2004

- Status
-
Public
- Employees
-
297

- Stock Symbol
-
430300

- Share Price
-
$2.48
- (As of Friday Closing)
Chenguang Medical General Information
Description
Shanghai Chenguang Medical Technologies Co Ltd engages in research and development, production, and sales of the core hardware of medical imaging superconducting MRI equipment and special magnets in the field of scientific research. The company's product system covers hardware of superconducting MRI devices, including: RF detectors, superconducting magnets, gradient coils, RF amplifiers, gradient amplifiers.
Contact Information
Website
www.shanghaicg.netCorporate Office
- No. 1269, Huaqing Road
- Qingpu District
- Shanghai, 201707
- China
Corporate Office
- No. 1269, Huaqing Road
- Qingpu District
- Shanghai, 201707
- China
Chenguang Medical Stock Performance
As of 18-Apr-2025, Chenguang Medical’s stock price is $2.48. Its current market cap is $212M with 85.8M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$2.48 | $2.52 | $0.88 - $3.48 | $212M | 85.8M | 10.1M | -$0.03 |
Chenguang Medical Financials Summary
As of 30-Sep-2024, Chenguang Medical has a trailing 12-month revenue of $21.2M.
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 125,560 | 189,727 | 87,465 | |
Revenue | 21,214 | 23,413 | 27,887 | 30,378 |
EBITDA | (3,282) | 518 | 6,300 | 6,975 |
Net Income | (2,891) | (1,665) | 3,487 | 3,755 |
Total Assets | 70,966 | 68,244 | 63,967 | 56,520 |
Total Debt | 25,817 | 20,503 | 13,032 | 12,807 |
Chenguang Medical Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Chenguang Medical Patents
Chenguang Medical Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3151026-A1 | Pre-amplifier for magnetic resonance imaging radio-frequency coil | Active | 27-May-2014 | ||
US-10338170-B2 | Pre-amplifier for magnetic resonance imaging radio-frequency coil | Active | 27-May-2014 | ||
US-20170139020-A1 | Pre-amplifier for magnetic resonance imaging radio-frequency coil | Active | 27-May-2014 | ||
EP-3151026-A4 | Pre-amplifier for magnetic resonance imaging radio-frequency coil | Active | 27-May-2014 | ||
EP-3151026-B1 | Pre-amplifier for magnetic resonance imaging radio-frequency coil | Active | 27-May-2014 | G01R33/3621 |
Chenguang Medical Signals
Chenguang Medical Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Chenguang Medical FAQs
-
When was Chenguang Medical founded?
Chenguang Medical was founded in 2004.
-
Where is Chenguang Medical headquartered?
Chenguang Medical is headquartered in Shanghai, China.
-
What is the size of Chenguang Medical?
Chenguang Medical has 297 total employees.
-
What industry is Chenguang Medical in?
Chenguang Medical’s primary industry is Other Commercial Products.
-
Is Chenguang Medical a private or public company?
Chenguang Medical is a Public company.
-
What is Chenguang Medical’s stock symbol?
The ticker symbol for Chenguang Medical is 430300.
-
What is the current stock price of Chenguang Medical?
As of 18-Apr-2025 the stock price of Chenguang Medical is $2.48.
-
What is the current market cap of Chenguang Medical?
The current market capitalization of Chenguang Medical is $212M.
-
What is Chenguang Medical’s current revenue?
The trailing twelve month revenue for Chenguang Medical is $21.2M.
-
What is Chenguang Medical’s annual earnings per share (EPS)?
Chenguang Medical’s EPS for 12 months was -$0.03.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »